Related references
Note: Only part of the references are listed.Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy
Mutsuki Kuraoka et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Mission critical: the need for proteomics in the era of next-generation sequencing and precision medicine
Devon M. Cayer et al.
HUMAN MOLECULAR GENETICS (2016)
Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype
Joana Capote et al.
JOURNAL OF CELL BIOLOGY (2016)
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy Report of the Guideline Development Subcommittee of the American Academy of Neurology
David Gloss et al.
NEUROLOGY (2016)
The mdx Mutation in the 129/Sv Background Results in a Milder Phenotype: Transcriptome Comparative Analysis Searching for the Protective Factors
Priscila Clara Calyjur et al.
PLOS ONE (2016)
Genetic Modifiers of Ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study
Luca Bello et al.
ANNALS OF NEUROLOGY (2015)
Conditions that promote primary human skeletal myoblast culture and muscle differentiation in vitro
Cindy S. Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage
Whitney L. Barfield et al.
HUMAN MOLECULAR GENETICS (2014)
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy
Sherry Dadgar et al.
JOURNAL OF CELL BIOLOGY (2014)
Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscle
Charles N. Pagel et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2014)
LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy
Kevin M. Flanigan et al.
ANNALS OF NEUROLOGY (2013)
Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways
E. R. Gimba et al.
CANCER LETTERS (2013)
Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury
Kitipong Uaesoontrachoon et al.
DISEASE MODELS & MECHANISMS (2013)
Alterations in Osteopontin Modify Muscle Size in Females in Both Humans and Mice
Eric P. Hoffman et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2013)
Age dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration
Preeti Paliwal et al.
AGING-US (2012)
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle
Luisa Piva et al.
JOURNAL OF PATHOLOGY (2012)
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
Luca Bello et al.
NEUROLOGY (2012)
Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis
Simona Zanotti et al.
HISTOPATHOLOGY (2011)
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
E. Pegoraro et al.
NEUROLOGY (2011)
Osteopontin, a chemotactic protein with cytokine-like properties, is up-regulated in muscle injury caused by Bothrops lanceolatus (fer-de-lance) snake venom
Valeria Barbosa-Souza et al.
TOXICON (2011)
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta
Sylvia A. Vetrone et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Osteopontin and skeletal muscle myoblasts: Association with muscle regeneration and regulation of myoblast function in vitro
Kitipong Uaesoontrachoon et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring
Ryoichi Mori et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells
Mari L. Shinohara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Immortalization of human myogenic progenitor cell clone retaining multipotentiality
Naohiro Hashimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy
YW Chen et al.
NEUROLOGY (2005)
Polymorphisms in the osteopontin promoter affect its transcriptional activity
F Giacopelli et al.
PHYSIOLOGICAL GENOMICS (2004)
Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice
JS Berman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection - A role for osteopontin
A Hirata et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle
JN Haslett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Function and genetics of dystrophin and dystrophin-related proteins in muscle
DJ Blake et al.
PHYSIOLOGICAL REVIEWS (2002)
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice
JD Porter et al.
HUMAN MOLECULAR GENETICS (2002)
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
DT Denhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
